Tsuyoshi Nakamaki
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Chronic neutrophilic leukemia preceded by myelodysplastic syndromes.
Journal: International journal of hematology
Published: February 17, 2023
Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: September 13, 2021
Increased serum C-reactive protein is an adverse prognostic factor in low-risk myelodysplastic syndromes.
Journal: International journal of hematology
Published: February 05, 2021
Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults.
Journal: International journal of hematology
Published: September 22, 2020
Corrigendum to 'Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults' [Biology of Blood and Marrow Transplantation 26/2 (2020) 367-372].
Journal: Transplantation and cellular therapy
Published: March 16, 2020
Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy.
Journal: International journal of hematology
Published: October 20, 2019
Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: July 14, 2019
Development of cardiac tamponade and emergence of arrhythmia during chemotherapy for diffuse large B-cell lymphoma
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: July 09, 2019
Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation.
Journal: Transplantation proceedings
Published: July 05, 2019
Natural Killer Immunotherapy for Minimal Residual Disease Eradication Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia.
Journal: International journal of molecular sciences
Published: April 05, 2019
Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 12, 2018
Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: September 25, 2018
Last Updated: 09/26/2026